NVISO takes strategic stake in ePAT

NVISO has reached agreement with ePAT (ASX: EPT) to provide a perpetual license for use of its artificial intelligence software.  ePAT is commercializing an innovative mobile application using artificial intelligence to analyze facial expressions to determine pain which has been given regulatory clearance in Europe and Australia. Highlights: •    Partnership between the two parties will accelerate […]

お問い合わせ先

NVISO MOBILE EVK

Please complete this form to receive purchasing instructions via email for the NVISO Mobile EVK.

REQUEST SDK

REQUEST SDK

DOWNLOAD WHITEPAPER